They can no longer remember your name, what they did yesterday, what to do with their keys, or even how to brush their teeth. As the disease progresses, they become more and more withdrawn, until eventually, they can no longer recognize the faces of their loved ones. It’s a heart-wrenching experience that I wouldn’t wish on anyone.

This is the reality for millions of people around the world who are affected by Alzheimer’s disease. While there is no cure for Alzheimer’s, there is hope. New research is providing insights into how we can better treat the disease.

One such study has found that targeting amyloid beta could be more effective than previously thought.

Amyloid-positive carriers of autosomal dominant Alzheimer’s disease-causing mutations were put under observation for 3 years.

The study found that higher levels of soluble Aβ42 predicted a lower risk of progression to cognitive impairment to a greater extent than lower levels of brain amyloid. In other words, it showed that treating Alzheimer’s disease by targeting amyloid beta could be more effective than previously thought.

This is an important finding that could change the way we approach Alzheimer’s disease treatment in the future.

For me, these hits close to home. My mother, mother-in-law, my brother-in-law, neighbor, sister’s mother-in-law, and I have watched as the disease slowly robbed families of their memories, their ability to communicate, and eventually their mobility.

To see that there might be a way to target the disease more effectively is very exciting. It gives me hope that one day we might be able to slow down or even stop the progression of Alzheimer’s and Give people like me and your loved ones some of their precious memories back.

Today my guest is Dr. Alberto Espay. Alberto Espay is a professor and endowed chair at the University of Cincinnati’s James J. and Joan A. Gardner Center for Parkinson’s disease.

He has published over 300 peer-reviewed research articles and 8 books, including Common Movement Disorders Pitfalls and Brain Fables: The Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer Them.

Espay has served as Chair of the Movement Disorders Section of the American Academy of Neurology, Associate Editor of the Movement Disorders journal, and on the Executive Committee of the Parkinson Study Group. He recently launched the first biomarker study of aging (

Upcoming Video

Related Article

Be the first to know

Post a Comment

Leave a Reply

Unleash Your Business's Potential with Cutting-Edge AI Solutions

With AI at the forefront of innovation, it’s time to tap into the power of artificial intelligence and unlock the full potential of your business. Our platform offers a range of AI solutions that can help you stay ahead of the curve and achieve new levels of success.

More Videos like this

  • All Post
  • Videos
Crafting Your AI Workforce with AutoGen Studio

LinkedIn Live Event: “Crafting Your AI Workforce with AutoGen Studio” February 22, 2024 11:00 am to 12:00 pm ET Event Highlights: 1. AI and the Future Workforce: Exploring how AI is transforming job roles and…

How To Ask AI Questions for Business Insights

Upgrade Your Approach to #AI in #Business! Join our LinkedIn Live event: 𝗗𝗮𝘁𝗮 𝗖𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻𝘀: 𝗛𝗼𝘄 𝘁𝗼 𝗔𝘀𝗸 𝗔𝗜 𝗦𝗺𝗮𝗿𝘁 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗕𝗲𝘁𝘁𝗲𝗿 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 February 8th, 11 AM – 12 PM ET Unlock the potential of…

Unlocking Business Insights with AI

Get ready to transform the way you interact with data! Join our LinkedIn Live session: 𝗗𝗮𝘁𝗮 𝗗𝗶𝗮𝗹𝗼𝗴𝘂𝗲𝘀: 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝘄𝗶𝘁𝗵 𝗔𝗜 February 1st, 11 AM – 12 PM ET Dive into the world of…


When The Content Is Ready, It Will Be Delivered To Your Inbox